Header cover image

Malaysian (KLSE) Pharma Industry Analysis

UpdatedJan 09, 2026
DataAggregated Company Financials
Companies6
  • 7D0.7%
  • 3M-0.008%
  • 1Y2.9%
  • YTD0.9%

Last week, the Pharma industry hasn't moved much but Duopharma Biotech Berhad is up 4.0% in that time. Furthermore, the industry has been flat for the past year as well. Looking forward, earnings are forecast to grow by 11% annually.

Industry Valuation and Performance

Has the Malaysian Pharma Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Fri, 09 Jan 2026RM 4.3bRM 2.8bRM 231.9m14.7x18.4x1.5x
Sun, 07 Dec 2025RM 4.2bRM 2.8bRM 231.9m14.5x18.1x1.5x
Tue, 04 Nov 2025RM 4.1bRM 2.8bRM 223.3m15.3x18.5x1.5x
Thu, 02 Oct 2025RM 4.1bRM 2.8bRM 223.3m15.5x18.4x1.5x
Sat, 30 Aug 2025RM 4.3bRM 2.8bRM 224.6m15.9x18.9x1.5x
Mon, 28 Jul 2025RM 4.3bRM 2.8bRM 230.3m15.8x18.5x1.5x
Wed, 25 Jun 2025RM 4.1bRM 2.8bRM 230.3m15.7x17.6x1.4x
Fri, 23 May 2025RM 3.9bRM 2.8bRM 233.0m15.3x16.9x1.4x
Sun, 20 Apr 2025RM 3.7bRM 2.8bRM 221.0m16.4x16.7x1.3x
Tue, 18 Mar 2025RM 3.7bRM 2.8bRM 221.0m16.3x16.8x1.3x
Thu, 13 Feb 2025RM 4.1bRM 2.7bRM 223.9m17.5x18.3x1.5x
Sat, 11 Jan 2025RM 4.1bRM 2.7bRM 223.9m17.7x18.4x1.5x
Mon, 09 Dec 2024RM 4.2bRM 2.7bRM 223.9m16.2x18.9x1.5x
Wed, 06 Nov 2024RM 4.3bRM 2.7bRM 230.0m14.3x18.8x1.6x
Fri, 04 Oct 2024RM 4.5bRM 2.7bRM 230.0m14.6x19.5x1.7x
Sun, 01 Sep 2024RM 4.3bRM 2.7bRM 230.0m14.6x18.7x1.6x
Tue, 30 Jul 2024RM 4.4bRM 2.6bRM 541.3m12.7x8.1x1.7x
Thu, 27 Jun 2024RM 4.5bRM 2.6bRM 541.3m13.3x8.3x1.7x
Sat, 25 May 2024RM 4.5bRM 2.6bRM 548.7m13.5x8.2x1.7x
Mon, 22 Apr 2024RM 4.5bRM 2.6bRM 559.3m12.2x8x1.7x
Wed, 20 Mar 2024RM 4.5bRM 2.6bRM 559.3m12.2x8.1x1.7x
Fri, 16 Feb 2024RM 4.7bRM 2.6bRM 584.9m12.3x8x1.8x
Sun, 14 Jan 2024RM 4.3bRM 2.6bRM 584.9m12.4x7.4x1.7x
Tue, 12 Dec 2023RM 4.1bRM 2.6bRM 584.9m12x7x1.6x
Thu, 09 Nov 2023RM 4.3bRM 2.6bRM 604.4m12.2x7x1.7x
Sat, 07 Oct 2023RM 4.2bRM 2.6bRM 604.4m12.2x7x1.6x
Mon, 04 Sep 2023RM 4.3bRM 2.6bRM 604.4m12.4x7.1x1.7x
Wed, 02 Aug 2023RM 4.4bRM 2.6bRM 304.7m14x14.4x1.7x
Fri, 30 Jun 2023RM 4.3bRM 2.6bRM 304.7m14.3x14x1.7x
Sun, 28 May 2023RM 4.7bRM 2.6bRM 305.1m13.6x15.3x1.8x
Tue, 25 Apr 2023RM 4.7bRM 2.5bRM 289.8m13.4x16.4x1.9x
Thu, 23 Mar 2023RM 4.7bRM 2.5bRM 289.8m13x16.1x1.9x
Sat, 18 Feb 2023RM 4.7bRM 2.4bRM 270.7m13.6x17.5x1.9x
Mon, 16 Jan 2023RM 4.7bRM 2.4bRM 270.7m12.8x17.4x1.9x
Price to Earnings Ratio

17.4x


Total Market Cap: RM 4.7bTotal Earnings: RM 270.7mTotal Revenue: RM 2.4bTotal Market Cap vs Earnings and Revenue0%0%0%
Malaysian Pharma Industry Price to Earnings3Y Average 14.2x202420252026
Current Industry PE
  • Investors are optimistic on the Malaysian Pharmaceuticals industry, and appear confident in long term growth rates.
  • The industry is trading at a PE ratio of 18.4x which is higher than its 3-year average PE of 14.2x.
  • The industry is trading close to its 3-year average PS ratio of 1.6x.
Past Earnings Growth
  • The earnings for companies in the Pharmaceuticals industry have declined 5.0% per year over the last three years.
  • Meanwhile revenues for these companies have grown 4.9% per year.
  • This means that although more sales are being generated, either the cost of doing business or the level of investment back into businesses has increased, which has decreased profits.

Industry Trends

Which industries have driven the changes within the Malaysian Healthcare industry?

MY Market0.68%
Healthcare-1.65%
Pharma0.69%
Pharma0.69%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
DPHARMA Duopharma Biotech BerhadRM 1.304.0%
+RM 48.1m
2.4%PE15x
KOTRA Kotra Industries BerhadRM 4.180.7%
+RM 4.4m
-4.1%PE14.5x
PLABS PeterLabs Holdings BerhadRM 0.252.0%
+RM 1.4m
22.0%PE28.4x

Latest News